Cargando…

SuPAR levels in BAL fluid from patients with acute respiratory distress syndrome—a pilot study

Detalles Bibliográficos
Autores principales:	Reisinger, Alexander C., Hackl, Gerald, Niedrist, Tobias, Hoenigl, Martin, Eller, Philipp, Prattes, Juergen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516241/ https://www.ncbi.nlm.nih.gov/pubmed/32977840 http://dx.doi.org/10.1186/s13054-020-03299-2

Ejemplares similares

Soluble urokinase plasminogen activator receptor (suPAR) predicts critical illness and kidney failure in patients admitted to the intensive care unit
por: Reisinger, Alexander C., et al.
Publicado: (2021)

suPAR remains uninfluenced by surgery in septic patients with bloodstream infection
por: Rabensteiner, Jasmin, et al.
Publicado: (2016)

suPAR and Team Nephrology
por: Trachtman, Howard
Publicado: (2014)

suPAR: The Molecular Crystal Ball
por: Thunø, Maria, et al.
Publicado: (2009)

suPAR: An Inflammatory Mediator for Kidneys
por: Sudhini, Yashwanth Reddy, et al.
Publicado: (2022)

suPAR as a prognostic biomarker in sepsis
por: Donadello, Katia, et al.
Publicado: (2012)

Reassessing the Reassessment of suPAR in Glomerular Disease
por: Meijers, Björn K. I., et al.
Publicado: (2015)

suPAR to Risk-Stratify Patients With Malaria
por: Stefanova, Veselina, et al.
Publicado: (2022)

suPAR, a Circulating Kidney Disease Factor
por: Wei, Changli, et al.
Publicado: (2021)

Pleural Fluid suPAR Levels Predict the Need for Invasive Management in Parapneumonic Effusions
por: Arnold, David T., et al.
Publicado: (2020)

suPAR in the assessment of post intensive care unit prognosis: a pilot study
por: Silvestre, Joana, et al.
Publicado: (2018)

Acute respiratory distress syndrome during a pandemic—an obvious diagnosis?
por: Reisinger, Alexander C, et al.
Publicado: (2020)

The Association of uPA, uPAR, and suPAR System with Inflammation and Joint Damage in Rheumatoid Arthritis: suPAR as a Biomarker in the Light of a Personalized Medicine Perspective
por: Benucci, Maurizio, et al.
Publicado: (2022)

SuPAR - A future prognostic biomarker in emergency medicine
por: Østervig, Rebecca M, et al.
Publicado: (2015)

Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis
por: Garnæs, Emilie, et al.
Publicado: (2019)

suPAR Surprises as a Biomarker of Invasive Outcomes in Pleural Infection
por: Idell, Steven, et al.
Publicado: (2020)

The Perspective of Vitamin D on suPAR-Related AKI in COVID-19
por: Liao, Tzu-Hsien, et al.
Publicado: (2022)

The Association of suPAR with Cardiovascular Risk Factors in Young and Healthy Adults
por: Wohlwend, Niklas Fabio, et al.
Publicado: (2023)

Neutrophils are a main source of circulating suPAR predicting outcome in critical illness
por: Gussen, Hendrik, et al.
Publicado: (2019)

Invasive pulmonary aspergillosis complicating COVID-19 in the ICU - A case report
por: Prattes, Juergen, et al.
Publicado: (2020)

Detection of suPAR in the Saliva of Healthy Young Adults: Comparison with Plasma Levels
por: Gustafsson, Anna, et al.
Publicado: (2011)

SuPAR predicts postoperative complications and mortality in patients with asymptomatic aortic stenosis
por: Hodges, Gethin W, et al.
Publicado: (2018)

Plasma levels of the active form of suPAR are associated with COVID-19 severity
por: Huang, Mingxiang, et al.
Publicado: (2020)

suPAR Cut-Offs for Risk Stratification in Patients With Symptoms of COVID-19
por: Altintas, Izzet, et al.
Publicado: (2021)

Assay-related differences in SuPAR levels: implications for measurement and data interpretation
por: Vasbinder, Alexi, et al.
Publicado: (2022)

Predictive value of suPAR in AKI: a systematic review and meta-analysis
por: Huang, Yan, et al.
Publicado: (2022)

Soluble urokinase plasminogen activator receptor (suPAR) in the emergency department: An update
por: Velissaris, Dimitrios, et al.
Publicado: (2022)

SuPAR mediates viral response proteinuria by rapidly changing podocyte function
por: Wei, Changli, et al.
Publicado: (2023)

Correction to: Neutrophils are a main source of circulating suPAR predicting outcome in critical illness
por: Gussen, Hendrik, et al.
Publicado: (2019)

Admission levels of Soluble Urokinase Plasminogen Activator Receptor (suPAR) are Associated with the Development of Severe Complications in Hospitalised COVID-19 Patients: A Prospective Cohort Study
por: Oulhaj, Abderrahim, et al.
Publicado: (2021)

The Prognostic Value of suPAR Compared to Other Inflammatory Markers in Patients with Severe Sepsis
por: Gustafsson, Anna, et al.
Publicado: (2012)

Utility of the Plasma Level of suPAR in Monitoring Risk of Mortality during TB Treatment
por: Rabna, Paulo, et al.
Publicado: (2012)

Innate immune response-mediated late increase in SuPAR in multi-trauma patients
por: Timmermans, K, et al.
Publicado: (2013)

Role of suPAR and Lactic Acid in Diagnosing Sepsis and Predicting Mortality in Elderly Patients
por: Khater, Walaa S., et al.
Publicado: (2016)

Healthy lifestyles reduce suPAR and mortality in a Danish general population study
por: Haupt, Thomas Huneck, et al.
Publicado: (2019)

Association Between Elevated suPAR, a New Biomarker of Inflammation, and Accelerated Aging
por: Rasmussen, Line Jee Hartmann, et al.
Publicado: (2020)

Kinetics of SuPAR hemoadsorption in critical COVID-19 patients on renal replacement therapy
por: Vicka, Vaidas, et al.
Publicado: (2022)

Detection of Inflammatory Biomarker suPAR in COVID-19 Disease With CHORUS TRIO Instrument
por: Helena, Cerutti, et al.
Publicado: (2023)

suPAR as a marker of infection in acute kidney injury – a prospective observational study
por: Hall, Anna, et al.
Publicado: (2018)

Serum soluble urokinase plasminogen activator receptor (suPAR) in adults with growth hormone deficiency
por: Höybye, Charlotte, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7d9ie0idku31l4ranjreusd2bq